Metabolic Disorders Therapeutics Market, Global Outlook and Forecast 2022-2028

March 2022 | 60 pages | ID: ME7BE4EAFA98EN
Market Monitor Global

Abstracts

Metabolic Disorders Therapeutics is a drug used to treat the symptoms of metabolic disorders caused by a variety of causes.

This report contains market size and forecasts of Metabolic Disorders Therapeutics in Global, including the following market information:

Global Metabolic Disorders Therapeutics Market Revenue, 2017-2022, 2023-2028, ($ millions)

Global top five companies in 2021 (%)

The global Metabolic Disorders Therapeutics market was valued at million in 2021 and is projected to reach US$ million by 2028, at a CAGR of % during the forecast period.

The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.

Metachromatic Leukodystrophy Segment to Reach $ Million by 2028, with a % CAGR in next six years.

The global key manufacturers of Metabolic Disorders Therapeutics include AbbVie, Novo Nordisk, Actelion Pharmaceuticals, Sanofi, Biocon, Merck, Boehringer Ingelheim, AstraZeneca and CymaBay Therapeutics and etc. In 2021, the global top five players have a share approximately % in terms of revenue.

MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Metabolic Disorders Therapeutics companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.

Total Market by Segment:

Global Metabolic Disorders Therapeutics Market, by Type, 2017-2022, 2023-2028 ($ millions)

Global Metabolic Disorders Therapeutics Market Segment Percentages, by Type, 2021 (%)

• Metachromatic Leukodystrophy
• Globoid Leukodystrophy
• Hepatic Encephalopathy
• Others

Global Metabolic Disorders Therapeutics Market, by Application, 2017-2022, 2023-2028 ($ millions)

Global Metabolic Disorders Therapeutics Market Segment Percentages, by Application, 2021 (%)

• Diabetes
• Obesity
• Hypercholesterolemia
• Lysosomal Storage Diseases
• Others

Global Metabolic Disorders Therapeutics Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions)

Global Metabolic Disorders Therapeutics Market Segment Percentages, By Region and Country, 2021 (%)

• North America
• US
• Canada
• Mexico
• Europe
• Germany
• France
• U.K.
• Italy
• Russia
• Nordic Countries
• Benelux
• Rest of Europe
• Asia
• China
• Japan
• South Korea
• Southeast Asia
• India
• Rest of Asia
• South America
• Brazil
• Argentina
• Rest of South America
• Middle East & Africa
• Turkey
• Israel
• Saudi Arabia
• UAE
• Rest of Middle East & Africa

Competitor Analysis

The report also provides analysis of leading market participants including:

Key companies Metabolic Disorders Therapeutics revenues in global market, 2017-2022 (estimated), ($ millions)

Key companies Metabolic Disorders Therapeutics revenues share in global market, 2021 (%)

Further, the report presents profiles of competitors in the market, key players include:

• AbbVie
• Novo Nordisk
• Actelion Pharmaceuticals
• Sanofi
• Biocon
• Merck
• Boehringer Ingelheim
• AstraZeneca
• CymaBay Therapeutics
• Eli Lilly and Company

Contents

1 INTRODUCTION TO RESEARCH & ANALYSIS REPORTS

1.1 Metabolic Disorders Therapeutics Market Definition
1.2 Market Segments
  1.2.1 Market by Type
  1.2.2 Market by Application
1.3 Global Metabolic Disorders Therapeutics Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
  1.5.1 Research Methodology
  1.5.2 Research Process
  1.5.3 Base Year
  1.5.4 Report Assumptions & Caveats

2 GLOBAL METABOLIC DISORDERS THERAPEUTICS OVERALL MARKET SIZE

2.1 Global Metabolic Disorders Therapeutics Market Size: 2021 VS 2028
2.2 Global Metabolic Disorders Therapeutics Market Size, Prospects & Forecasts: 2017-2028
2.3 Key Market Trends, Opportunity, Drivers and Restraints
  2.3.1 Market Opportunities & Trends
  2.3.2 Market Drivers
  2.3.3 Market Restraints

3 COMPANY LANDSCAPE

3.1 Top Metabolic Disorders Therapeutics Players in Global Market
3.2 Top Global Metabolic Disorders Therapeutics Companies Ranked by Revenue
3.3 Global Metabolic Disorders Therapeutics Revenue by Companies
3.4 Top 3 and Top 5 Metabolic Disorders Therapeutics Companies in Global Market, by Revenue in 2021
3.5 Global Companies Metabolic Disorders Therapeutics Product Type
3.6 Tier 1, Tier 2 and Tier 3 Metabolic Disorders Therapeutics Players in Global Market
  3.6.1 List of Global Tier 1 Metabolic Disorders Therapeutics Companies
  3.6.2 List of Global Tier 2 and Tier 3 Metabolic Disorders Therapeutics Companies

4 MARKET SIGHTS BY PRODUCT

4.1 Overview
  4.1.1 by Type - Global Metabolic Disorders Therapeutics Market Size Markets, 2021 & 2028
  4.1.2 Metachromatic Leukodystrophy
  4.1.3 Globoid Leukodystrophy
  4.1.4 Hepatic Encephalopathy
  4.1.5 Others
4.2 By Type - Global Metabolic Disorders Therapeutics Revenue & Forecasts
  4.2.1 By Type - Global Metabolic Disorders Therapeutics Revenue, 2017-2022
  4.2.2 By Type - Global Metabolic Disorders Therapeutics Revenue, 2023-2028
  4.2.3 By Type - Global Metabolic Disorders Therapeutics Revenue Market Share, 2017-2028

5 SIGHTS BY APPLICATION

5.1 Overview
  5.1.1 By Application - Global Metabolic Disorders Therapeutics Market Size, 2021 & 2028
  5.1.2 Diabetes
  5.1.3 Obesity
  5.1.4 Hypercholesterolemia
  5.1.5 Lysosomal Storage Diseases
  5.1.6 Others
5.2 By Application - Global Metabolic Disorders Therapeutics Revenue & Forecasts
  5.2.1 By Application - Global Metabolic Disorders Therapeutics Revenue, 2017-2022
  5.2.2 By Application - Global Metabolic Disorders Therapeutics Revenue, 2023-2028
  5.2.3 By Application - Global Metabolic Disorders Therapeutics Revenue Market Share, 2017-2028

6 SIGHTS BY REGION

6.1 By Region - Global Metabolic Disorders Therapeutics Market Size, 2021 & 2028
6.2 By Region - Global Metabolic Disorders Therapeutics Revenue & Forecasts
  6.2.1 By Region - Global Metabolic Disorders Therapeutics Revenue, 2017-2022
  6.2.2 By Region - Global Metabolic Disorders Therapeutics Revenue, 2023-2028
  6.2.3 By Region - Global Metabolic Disorders Therapeutics Revenue Market Share, 2017-2028
6.3 North America
  6.3.1 By Country - North America Metabolic Disorders Therapeutics Revenue, 2017-2028
  6.3.2 US Metabolic Disorders Therapeutics Market Size, 2017-2028
  6.3.3 Canada Metabolic Disorders Therapeutics Market Size, 2017-2028
  6.3.4 Mexico Metabolic Disorders Therapeutics Market Size, 2017-2028
6.4 Europe
  6.4.1 By Country - Europe Metabolic Disorders Therapeutics Revenue, 2017-2028
  6.4.2 Germany Metabolic Disorders Therapeutics Market Size, 2017-2028
  6.4.3 France Metabolic Disorders Therapeutics Market Size, 2017-2028
  6.4.4 U.K. Metabolic Disorders Therapeutics Market Size, 2017-2028
  6.4.5 Italy Metabolic Disorders Therapeutics Market Size, 2017-2028
  6.4.6 Russia Metabolic Disorders Therapeutics Market Size, 2017-2028
  6.4.7 Nordic Countries Metabolic Disorders Therapeutics Market Size, 2017-2028
  6.4.8 Benelux Metabolic Disorders Therapeutics Market Size, 2017-2028
6.5 Asia
  6.5.1 By Region - Asia Metabolic Disorders Therapeutics Revenue, 2017-2028
  6.5.2 China Metabolic Disorders Therapeutics Market Size, 2017-2028
  6.5.3 Japan Metabolic Disorders Therapeutics Market Size, 2017-2028
  6.5.4 South Korea Metabolic Disorders Therapeutics Market Size, 2017-2028
  6.5.5 Southeast Asia Metabolic Disorders Therapeutics Market Size, 2017-2028
  6.5.6 India Metabolic Disorders Therapeutics Market Size, 2017-2028
6.6 South America
  6.6.1 By Country - South America Metabolic Disorders Therapeutics Revenue, 2017-2028
  6.6.2 Brazil Metabolic Disorders Therapeutics Market Size, 2017-2028
  6.6.3 Argentina Metabolic Disorders Therapeutics Market Size, 2017-2028
6.7 Middle East & Africa
  6.7.1 By Country - Middle East & Africa Metabolic Disorders Therapeutics Revenue, 2017-2028
  6.7.2 Turkey Metabolic Disorders Therapeutics Market Size, 2017-2028
  6.7.3 Israel Metabolic Disorders Therapeutics Market Size, 2017-2028
  6.7.4 Saudi Arabia Metabolic Disorders Therapeutics Market Size, 2017-2028
  6.7.5 UAE Metabolic Disorders Therapeutics Market Size, 2017-2028

7 PLAYERS PROFILES

7.1 AbbVie
  7.1.1 AbbVie Corporate Summary
  7.1.2 AbbVie Business Overview
  7.1.3 AbbVie Metabolic Disorders Therapeutics Major Product Offerings
  7.1.4 AbbVie Metabolic Disorders Therapeutics Revenue in Global Market (2017-2022)
  7.1.5 AbbVie Key News
7.2 Novo Nordisk
  7.2.1 Novo Nordisk Corporate Summary
  7.2.2 Novo Nordisk Business Overview
  7.2.3 Novo Nordisk Metabolic Disorders Therapeutics Major Product Offerings
  7.2.4 Novo Nordisk Metabolic Disorders Therapeutics Revenue in Global Market (2017-2022)
  7.2.5 Novo Nordisk Key News
7.3 Actelion Pharmaceuticals
  7.3.1 Actelion Pharmaceuticals Corporate Summary
  7.3.2 Actelion Pharmaceuticals Business Overview
  7.3.3 Actelion Pharmaceuticals Metabolic Disorders Therapeutics Major Product Offerings
  7.3.4 Actelion Pharmaceuticals Metabolic Disorders Therapeutics Revenue in Global Market (2017-2022)
  7.3.5 Actelion Pharmaceuticals Key News
7.4 Sanofi
  7.4.1 Sanofi Corporate Summary
  7.4.2 Sanofi Business Overview
  7.4.3 Sanofi Metabolic Disorders Therapeutics Major Product Offerings
  7.4.4 Sanofi Metabolic Disorders Therapeutics Revenue in Global Market (2017-2022)
  7.4.5 Sanofi Key News
7.5 Biocon
  7.5.1 Biocon Corporate Summary
  7.5.2 Biocon Business Overview
  7.5.3 Biocon Metabolic Disorders Therapeutics Major Product Offerings
  7.5.4 Biocon Metabolic Disorders Therapeutics Revenue in Global Market (2017-2022)
  7.5.5 Biocon Key News
7.6 Merck
  7.6.1 Merck Corporate Summary
  7.6.2 Merck Business Overview
  7.6.3 Merck Metabolic Disorders Therapeutics Major Product Offerings
  7.6.4 Merck Metabolic Disorders Therapeutics Revenue in Global Market (2017-2022)
  7.6.5 Merck Key News
7.7 Boehringer Ingelheim
  7.7.1 Boehringer Ingelheim Corporate Summary
  7.7.2 Boehringer Ingelheim Business Overview
  7.7.3 Boehringer Ingelheim Metabolic Disorders Therapeutics Major Product Offerings
  7.7.4 Boehringer Ingelheim Metabolic Disorders Therapeutics Revenue in Global Market (2017-2022)
  7.7.5 Boehringer Ingelheim Key News
7.8 AstraZeneca
  7.8.1 AstraZeneca Corporate Summary
  7.8.2 AstraZeneca Business Overview
  7.8.3 AstraZeneca Metabolic Disorders Therapeutics Major Product Offerings
  7.8.4 AstraZeneca Metabolic Disorders Therapeutics Revenue in Global Market (2017-2022)
  7.8.5 AstraZeneca Key News
7.9 CymaBay Therapeutics
  7.9.1 CymaBay Therapeutics Corporate Summary
  7.9.2 CymaBay Therapeutics Business Overview
  7.9.3 CymaBay Therapeutics Metabolic Disorders Therapeutics Major Product Offerings
  7.9.4 CymaBay Therapeutics Metabolic Disorders Therapeutics Revenue in Global Market (2017-2022)
  7.9.5 CymaBay Therapeutics Key News
7.10 Eli Lilly and Company
  7.10.1 Eli Lilly and Company Corporate Summary
  7.10.2 Eli Lilly and Company Business Overview
  7.10.3 Eli Lilly and Company Metabolic Disorders Therapeutics Major Product Offerings
  7.10.4 Eli Lilly and Company Metabolic Disorders Therapeutics Revenue in Global Market (2017-2022)
  7.10.5 Eli Lilly and Company Key News

8 CONCLUSION

9 APPENDIX

9.1 Note
9.2 Examples of Clients
9.3 Disclaimer

List Of Tables

LIST OF TABLES

Table 1. Metabolic Disorders Therapeutics Market Opportunities & Trends in Global Market
Table 2. Metabolic Disorders Therapeutics Market Drivers in Global Market
Table 3. Metabolic Disorders Therapeutics Market Restraints in Global Market
Table 4. Key Players of Metabolic Disorders Therapeutics in Global Market
Table 5. Top Metabolic Disorders Therapeutics Players in Global Market, Ranking by Revenue (2021)
Table 6. Global Metabolic Disorders Therapeutics Revenue by Companies, (US$, Mn), 2017-2022
Table 7. Global Metabolic Disorders Therapeutics Revenue Share by Companies, 2017-2022
Table 8. Global Companies Metabolic Disorders Therapeutics Product Type
Table 9. List of Global Tier 1 Metabolic Disorders Therapeutics Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Metabolic Disorders Therapeutics Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 11. By Type – Global Metabolic Disorders Therapeutics Revenue, (US$, Mn), 2021 & 2028
Table 12. By Type - Metabolic Disorders Therapeutics Revenue in Global (US$, Mn), 2017-2022
Table 13. By Type - Metabolic Disorders Therapeutics Revenue in Global (US$, Mn), 2023-2028
Table 14. By Application – Global Metabolic Disorders Therapeutics Revenue, (US$, Mn), 2021 & 2028
Table 15. By Application - Metabolic Disorders Therapeutics Revenue in Global (US$, Mn), 2017-2022
Table 16. By Application - Metabolic Disorders Therapeutics Revenue in Global (US$, Mn), 2023-2028
Table 17. By Region – Global Metabolic Disorders Therapeutics Revenue, (US$, Mn), 2021 & 2028
Table 18. By Region - Global Metabolic Disorders Therapeutics Revenue (US$, Mn), 2017-2022
Table 19. By Region - Global Metabolic Disorders Therapeutics Revenue (US$, Mn), 2023-2028
Table 20. By Country - North America Metabolic Disorders Therapeutics Revenue, (US$, Mn), 2017-2022
Table 21. By Country - North America Metabolic Disorders Therapeutics Revenue, (US$, Mn), 2023-2028
Table 22. By Country - Europe Metabolic Disorders Therapeutics Revenue, (US$, Mn), 2017-2022
Table 23. By Country - Europe Metabolic Disorders Therapeutics Revenue, (US$, Mn), 2023-2028
Table 24. By Region - Asia Metabolic Disorders Therapeutics Revenue, (US$, Mn), 2017-2022
Table 25. By Region - Asia Metabolic Disorders Therapeutics Revenue, (US$, Mn), 2023-2028
Table 26. By Country - South America Metabolic Disorders Therapeutics Revenue, (US$, Mn), 2017-2022
Table 27. By Country - South America Metabolic Disorders Therapeutics Revenue, (US$, Mn), 2023-2028
Table 28. By Country - Middle East & Africa Metabolic Disorders Therapeutics Revenue, (US$, Mn), 2017-2022
Table 29. By Country - Middle East & Africa Metabolic Disorders Therapeutics Revenue, (US$, Mn), 2023-2028
Table 30. AbbVie Corporate Summary
Table 31. AbbVie Metabolic Disorders Therapeutics Product Offerings
Table 32. AbbVie Metabolic Disorders Therapeutics Revenue (US$, Mn), (2017-2022)
Table 33. Novo Nordisk Corporate Summary
Table 34. Novo Nordisk Metabolic Disorders Therapeutics Product Offerings
Table 35. Novo Nordisk Metabolic Disorders Therapeutics Revenue (US$, Mn), (2017-2022)
Table 36. Actelion Pharmaceuticals Corporate Summary
Table 37. Actelion Pharmaceuticals Metabolic Disorders Therapeutics Product Offerings
Table 38. Actelion Pharmaceuticals Metabolic Disorders Therapeutics Revenue (US$, Mn), (2017-2022)
Table 39. Sanofi Corporate Summary
Table 40. Sanofi Metabolic Disorders Therapeutics Product Offerings
Table 41. Sanofi Metabolic Disorders Therapeutics Revenue (US$, Mn), (2017-2022)
Table 42. Biocon Corporate Summary
Table 43. Biocon Metabolic Disorders Therapeutics Product Offerings
Table 44. Biocon Metabolic Disorders Therapeutics Revenue (US$, Mn), (2017-2022)
Table 45. Merck Corporate Summary
Table 46. Merck Metabolic Disorders Therapeutics Product Offerings
Table 47. Merck Metabolic Disorders Therapeutics Revenue (US$, Mn), (2017-2022)
Table 48. Boehringer Ingelheim Corporate Summary
Table 49. Boehringer Ingelheim Metabolic Disorders Therapeutics Product Offerings
Table 50. Boehringer Ingelheim Metabolic Disorders Therapeutics Revenue (US$, Mn), (2017-2022)
Table 51. AstraZeneca Corporate Summary
Table 52. AstraZeneca Metabolic Disorders Therapeutics Product Offerings
Table 53. AstraZeneca Metabolic Disorders Therapeutics Revenue (US$, Mn), (2017-2022)
Table 54. CymaBay Therapeutics Corporate Summary
Table 55. CymaBay Therapeutics Metabolic Disorders Therapeutics Product Offerings
Table 56. CymaBay Therapeutics Metabolic Disorders Therapeutics Revenue (US$, Mn), (2017-2022)
Table 57. Eli Lilly and Company Corporate Summary
Table 58. Eli Lilly and Company Metabolic Disorders Therapeutics Product Offerings
Table 59. Eli Lilly and Company Metabolic Disorders Therapeutics Revenue (US$, Mn), (2017-2022)

List Of Figures

LIST OF FIGURES

Figure 1. Metabolic Disorders Therapeutics Segment by Type in 2021
Figure 2. Metabolic Disorders Therapeutics Segment by Application in 2021
Figure 3. Global Metabolic Disorders Therapeutics Market Overview: 2021
Figure 4. Key Caveats
Figure 5. Global Metabolic Disorders Therapeutics Market Size: 2021 VS 2028 (US$, Mn)
Figure 6. Global Metabolic Disorders Therapeutics Revenue, 2017-2028 (US$, Mn)
Figure 7. The Top 3 and 5 Players Market Share by Metabolic Disorders Therapeutics Revenue in 2021
Figure 8. By Type - Global Metabolic Disorders Therapeutics Revenue Market Share, 2017-2028
Figure 9. By Application - Global Metabolic Disorders Therapeutics Revenue Market Share, 2017-2028
Figure 10. By Region - Global Metabolic Disorders Therapeutics Revenue Market Share, 2017-2028
Figure 11. By Country - North America Metabolic Disorders Therapeutics Revenue Market Share, 2017-2028
Figure 12. US Metabolic Disorders Therapeutics Revenue, (US$, Mn), 2017-2028
Figure 13. Canada Metabolic Disorders Therapeutics Revenue, (US$, Mn), 2017-2028
Figure 14. Mexico Metabolic Disorders Therapeutics Revenue, (US$, Mn), 2017-2028
Figure 15. By Country - Europe Metabolic Disorders Therapeutics Revenue Market Share, 2017-2028
Figure 16. Germany Metabolic Disorders Therapeutics Revenue, (US$, Mn), 2017-2028
Figure 17. France Metabolic Disorders Therapeutics Revenue, (US$, Mn), 2017-2028
Figure 18. U.K. Metabolic Disorders Therapeutics Revenue, (US$, Mn), 2017-2028
Figure 19. Italy Metabolic Disorders Therapeutics Revenue, (US$, Mn), 2017-2028
Figure 20. Russia Metabolic Disorders Therapeutics Revenue, (US$, Mn), 2017-2028
Figure 21. Nordic Countries Metabolic Disorders Therapeutics Revenue, (US$, Mn), 2017-2028
Figure 22. Benelux Metabolic Disorders Therapeutics Revenue, (US$, Mn), 2017-2028
Figure 23. By Region - Asia Metabolic Disorders Therapeutics Revenue Market Share, 2017-2028
Figure 24. China Metabolic Disorders Therapeutics Revenue, (US$, Mn), 2017-2028
Figure 25. Japan Metabolic Disorders Therapeutics Revenue, (US$, Mn), 2017-2028
Figure 26. South Korea Metabolic Disorders Therapeutics Revenue, (US$, Mn), 2017-2028
Figure 27. Southeast Asia Metabolic Disorders Therapeutics Revenue, (US$, Mn), 2017-2028
Figure 28. India Metabolic Disorders Therapeutics Revenue, (US$, Mn), 2017-2028
Figure 29. By Country - South America Metabolic Disorders Therapeutics Revenue Market Share, 2017-2028
Figure 30. Brazil Metabolic Disorders Therapeutics Revenue, (US$, Mn), 2017-2028
Figure 31. Argentina Metabolic Disorders Therapeutics Revenue, (US$, Mn), 2017-2028
Figure 32. By Country - Middle East & Africa Metabolic Disorders Therapeutics Revenue Market Share, 2017-2028
Figure 33. Turkey Metabolic Disorders Therapeutics Revenue, (US$, Mn), 2017-2028
Figure 34. Israel Metabolic Disorders Therapeutics Revenue, (US$, Mn), 2017-2028
Figure 35. Saudi Arabia Metabolic Disorders Therapeutics Revenue, (US$, Mn), 2017-2028
Figure 36. UAE Metabolic Disorders Therapeutics Revenue, (US$, Mn), 2017-2028
Figure 37. AbbVie Metabolic Disorders Therapeutics Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 38. Novo Nordisk Metabolic Disorders Therapeutics Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 39. Actelion Pharmaceuticals Metabolic Disorders Therapeutics Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 40. Sanofi Metabolic Disorders Therapeutics Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 41. Biocon Metabolic Disorders Therapeutics Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 42. Merck Metabolic Disorders Therapeutics Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 43. Boehringer Ingelheim Metabolic Disorders Therapeutics Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 44. AstraZeneca Metabolic Disorders Therapeutics Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 45. CymaBay Therapeutics Metabolic Disorders Therapeutics Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 46. Eli Lilly and Company Metabolic Disorders Therapeutics Revenue Year Over Year Growth (US$, Mn) & (2017-2022)